Ross\Johnson & Associates LLC Haleon PLC Transaction History
Ross\Johnson & Associates LLC
- $4.32 Billion
- Q4 2024
A detailed history of Ross\Johnson & Associates LLC transactions in Haleon PLC stock. As of the latest transaction made, Ross\Johnson & Associates LLC holds 30 shares of HLN stock, worth $299. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30Holding current value
$299% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HLN
# of Institutions
659Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.79 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$328 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$241 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$153 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$98.8 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $46.1B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...